Beclomethasone Dipropionate Global Patent Coverage & Expiry Overview

Track protection status across key markets to assess launch feasibility.

Start your free 7-Day Trial! Book a demo to explore our global patent data.

It is formulated by 2 pharmaceutical companies such as TEVA BRANDED PHARM, NORTON WATERFORD. It is marketed under 2 brand names, including QNASL, QVAR REDIHALER. Available in 4 different strengths, such as 0.08MG/ACTUATION, 0.04MG/ACTUATION, 0.04MG/INH and others, and administered through 2 routes including AEROSOL, METERED;NASAL, AEROSOL, METERED;INHALATION.

Strategic Dashboard

info

insightsStrategic Insights

Sourcing & Feasibility

check_circle API availability: autorenew Loading API feasibility...

groups Licensing: 2 potential partners

calendar_todayUS Launch window: autorenew Loading launch window...

timeline Key Patent Barrier & Expiry Timeline

autorenew Loading patent barriers...

factoryGeneric Manufacturer Snapshot

autorenew Loading manufacturers...

gavelRisk & Opportunity Summary

dangerous Risk: autorenew Loading risk analysis...
watch_later Watch: autorenew Loading watch analysis...
rocket_launch Opportunity: autorenew Loading opportunity analysis...
flag
gavel
calendar_today
calendar_today

Access Global Patent Data

Stay ahead with worldwide patent expiry and latest updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
Unlock Global Patents

Orange Book Drug Approval Timeline

FDA approval history for this ingredient

NDA (New Drug Application) ANDA (Generic Application)

Access Global Exclusivity and Patent Expiry Extensions

Stay ahead with worldwide patent expiry insights, exclusivity data, and latest updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
✓ Latest exclusivity data and extensions
Unlock Global Access

US Orange Book Patents Expiration Timeline

Key expiration dates for US patents covering this ingredient

View Global Patents Expiration Timeline

Stay ahead with worldwide patent expiry insights, market data, and research updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
Unlock Global Patent Timeline

Orange Book Drug Strengths

Latest drug strengths approved by FDA

Strength Route of Administration Companies Latest Approval Date

Orange Book Patents

Patents approved by the FDA for the ingredient

Patent Number Publication Date Legal Status Patent Expiry Date
{"application_id":"43441","ingredient":"BECLOMETHASONE DIPROPIONATE","trade_name":"QNASL","family_id":"8997e1dd7d1b4a4597ab","publication_number":"US7780038B2","cleaned_patent_number":"7780038","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-01-24","publication_date":"2010-08-24","legal_status":"Granted"} US7780038B2 Formulation 24 Aug, 2010 Granted 24 Jan, 2027
{"application_id":"39297","ingredient":"BECLOMETHASONE DIPROPIONATE","trade_name":"QVAR REDIHALER","family_id":"c8db115641a54ad8a687","publication_number":"US8132712B2","cleaned_patent_number":"8132712","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2028-09-07","publication_date":"2012-03-13","legal_status":"Granted"} US8132712B2 Formulation 13 Mar, 2012 Granted 07 Sep, 2028
{"application_id":"39276","ingredient":"BECLOMETHASONE DIPROPIONATE","trade_name":"QVAR 40","family_id":"feffce0b035848e1a6c3","publication_number":"US10086156B2","cleaned_patent_number":"10086156","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2031-05-18","publication_date":"2018-10-02","legal_status":"Granted"} US10086156B2 Formulation 02 Oct, 2018 Granted 18 May, 2031
{"application_id":"39116","ingredient":"BECLOMETHASONE DIPROPIONATE","trade_name":"QVAR 40","family_id":"feffce0b035848e1a6c3","publication_number":"US10695512B2","cleaned_patent_number":"10695512","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2031-05-18","publication_date":"2020-06-30","legal_status":"Granted"} US10695512B2 Formulation 30 Jun, 2020 Granted 18 May, 2031
{"application_id":"39274","ingredient":"BECLOMETHASONE DIPROPIONATE","trade_name":"QVAR 40","family_id":"feffce0b035848e1a6c3","publication_number":"US10022509B2","cleaned_patent_number":"10022509","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2031-05-18","publication_date":"2018-07-17","legal_status":"Granted"} US10022509B2 Formulation 17 Jul, 2018 Granted 18 May, 2031
{"application_id":"39275","ingredient":"BECLOMETHASONE DIPROPIONATE","trade_name":"QVAR 40","family_id":"feffce0b035848e1a6c3","publication_number":"US10022510B2","cleaned_patent_number":"10022510","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2031-05-18","publication_date":"2018-07-17","legal_status":"Granted"} US10022510B2 Formulation 17 Jul, 2018 Granted 18 May, 2031
{"application_id":"39280","ingredient":"BECLOMETHASONE DIPROPIONATE","trade_name":"QVAR REDIHALER","family_id":"feffce0b035848e1a6c3","publication_number":"US11395889B2","cleaned_patent_number":"11395889","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2031-05-18","publication_date":"2022-07-26","legal_status":"Granted"} US11395889B2 Formulation 26 Jul, 2022 Granted 18 May, 2031
{"application_id":"39267","ingredient":"BECLOMETHASONE DIPROPIONATE","trade_name":"QVAR 40","family_id":"feffce0b035848e1a6c3","publication_number":"US9463289B2","cleaned_patent_number":"9463289","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2031-05-18","publication_date":"2016-10-11","legal_status":"Granted"} US9463289B2 Formulation 11 Oct, 2016 Granted 18 May, 2031
{"application_id":"39273","ingredient":"BECLOMETHASONE DIPROPIONATE","trade_name":"QVAR 40","family_id":"feffce0b035848e1a6c3","publication_number":"US9808587B2","cleaned_patent_number":"9808587","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2031-05-18","publication_date":"2017-11-07","legal_status":"Granted"} US9808587B2 Formulation 07 Nov, 2017 Granted 18 May, 2031
{"application_id":"43373","ingredient":"BECLOMETHASONE DIPROPIONATE","trade_name":"QVAR REDIHALER","family_id":"edff9810f2624cb29c0f","publication_number":"US8931476B2","cleaned_patent_number":"8931476","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2031-07-17","publication_date":"2015-01-13","legal_status":"Granted"} US8931476B2 Formulation 13 Jan, 2015 Granted 17 Jul, 2031
{"application_id":"43448","ingredient":"BECLOMETHASONE DIPROPIONATE","trade_name":"QNASL","family_id":"61a37009420f484a9c64","publication_number":"US10188811B2","cleaned_patent_number":"10188811","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2031-10-21","publication_date":"2019-01-29","legal_status":"Granted"} US10188811B2 Formulation 29 Jan, 2019 Granted 21 Oct, 2031
{"application_id":"39279","ingredient":"BECLOMETHASONE DIPROPIONATE","trade_name":"QVAR REDIHALER","family_id":"feffce0b035848e1a6c3","publication_number":"US10561808B2","cleaned_patent_number":"10561808","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-01-01","publication_date":"2020-02-18","legal_status":"Granted"} US10561808B2 Formulation 18 Feb, 2020 Granted 01 Jan, 2032
{"application_id":"111265","ingredient":"BECLOMETHASONE DIPROPIONATE","trade_name":"QVAR REDIHALER","family_id":"7559eb6a9edd4ac397ad","publication_number":"US11896759B2","cleaned_patent_number":"11896759","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2038-01-26","publication_date":"2024-02-13","legal_status":"Granted"} US11896759B2 Formulation 13 Feb, 2024 Granted 26 Jan, 2038
{"application_id":"130592","ingredient":"BECLOMETHASONE DIPROPIONATE","trade_name":"QVAR REDIHALER","family_id":"8a1a340ec6f44e19b3b8","publication_number":"US2012296089A1","cleaned_patent_number":"12296089","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2038-01-26","publication_date":"2012-11-22","legal_status":"Pending"} US12296089B2 Formulation 22 Nov, 2012 Pending 26 Jan, 2038
{"application_id":"111607","ingredient":"BECLOMETHASONE DIPROPIONATE","trade_name":"QVAR REDIHALER","family_id":"3e5051d5265a4aa1ae29","publication_number":"US11793953B2","cleaned_patent_number":"11793953","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2038-01-26","publication_date":"2023-10-24","legal_status":"Granted"} US11793953B2 Formulation 24 Oct, 2023 Granted 26 Jan, 2038
{"application_id":"120488","ingredient":"BECLOMETHASONE DIPROPIONATE","trade_name":"QVAR REDIHALER","family_id":"","publication_number":"US11865247B2","cleaned_patent_number":"11865247","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2038-01-26","publication_date":"2024-01-09","legal_status":"Granted"} US11865247B2 Formulation 09 Jan, 2024 Granted 26 Jan, 2038
{"application_id":"105450","ingredient":"BECLOMETHASONE DIPROPIONATE","trade_name":"QVAR REDIHALER","family_id":"5a9fb39fd81040a98c50","publication_number":"US11395888B2","cleaned_patent_number":"11395888","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2038-01-26","publication_date":"2022-07-26","legal_status":"Granted"} US11395888B2 Formulation 26 Jul, 2022 Granted 26 Jan, 2038
{"application_id":"43361","ingredient":"BECLOMETHASONE DIPROPIONATE","trade_name":"QVAR REDIHALER","family_id":"c5056ff4a98d4050bdda","publication_number":"US10792447B2","cleaned_patent_number":"10792447","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2039-01-25","publication_date":"2020-10-06","legal_status":"Granted"} US10792447B2 Formulation 06 Oct, 2020 Granted 25 Jan, 2039
{"application_id":"111258","ingredient":"BECLOMETHASONE DIPROPIONATE","trade_name":"QVAR REDIHALER","family_id":"7559eb6a9edd4ac397ad","publication_number":"US11559637B2","cleaned_patent_number":"11559637","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2039-07-21","publication_date":"2023-01-24","legal_status":"Granted"} US11559637B2 Formulation 24 Jan, 2023 Granted 21 Jul, 2039
{"application_id":"43371","ingredient":"BECLOMETHASONE DIPROPIONATE","trade_name":"QVAR REDIHALER","family_id":"c5056ff4a98d4050bdda","publication_number":"US11957832B2","cleaned_patent_number":"11957832","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2041-05-05","publication_date":"2024-04-16","legal_status":"Granted"} US11957832B2 Formulation 16 Apr, 2024 Granted 05 May, 2041
{"application_id":"111601","ingredient":"BECLOMETHASONE DIPROPIONATE","trade_name":"QVAR REDIHALER","family_id":"0a80bdb9b6644123a780","publication_number":"US11583643B2","cleaned_patent_number":"11583643","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2041-08-19","publication_date":"2023-02-21","legal_status":"Granted"} US11583643B2 Formulation 21 Feb, 2023 Granted 19 Aug, 2041

Recent Clinical Trials

Latest clinical trials and research studies for this ingredient

NCT ID Title Status Phase Conditions Start Date Completion Date

API Suppliers/Manufacturer (Branded/Generic companies)

Manufacturing Locations

View Complete Supplier List

Unlock access to all suppliers of Beclomethasone Dipropionate

✓ Access a comprehensive list of global suppliers
✓ Get information on each supplier
Unlock Suppliers

Note: Patent expirations and exclusivity timelines are dynamic and may shift based on litigation, regulatory extensions, and maintenance filings. Regular monitoring is advised.

GreyB © 2025 Elixir. All rights reserved.